Navigation Links
China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
Date:11/10/2008

GUANGZHOU, China, Nov. 10 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading developer and distributor of prescription and over the counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Thursday, Nov. 13, 2008 to discuss its third quarter 2008 results.

Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of China Medicine Corporation, will be Ms. Huizhen Yu, Chief Financial Officer. The Company plans to make an earnings announcement prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888.482.0024. International callers should dial 617.801.9702, Conference Passcode: 501 582 39.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, Nov. 13, at 11:00 a.m. Eastern Time. To access the replay, dial 888-286-8010, international callers dial 617-801-6888, and enter the passcode of 11677443.

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers, develops, and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine ("TCM") products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, over 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the global...a,s patent office is now the world,s leading produ... China trailed Japan,s patent office, the World In...nited States Patent and Trademark Office (USPTO) f...5, WIPO in 2006, and exceeded Japan for the first ...
(Date:11/23/2009)...ov. 23, 2009 In a provocative new study, a Univer...ioxide emissions the major cause of global warmin... collapses or society builds the equivalent of one...unlikely that there will be any substantial near-t...in carbon dioxide emission rates," says the new pa...
(Date:11/23/2009)...promises ultra-fast communication, computation and...on. But trying to use quantum states as carriers o...ow two physicists have shown, mathematically, how ...unication, while keeping the information intact. T...sical Review Letters and highlighted with a Viewp...
(Date:11/23/2009)...GE,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBioPharma...asestablishedNovember27,2009astheex-dividenddatefo...ingfromthesecuritizationtransactioncompletedonNove...oallstockholdersofrecordontherecorddate,December1,...dividendat$1.67pershareofcommonstockforpurposesoft...
Breaking Biology Technology:China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...d CLAREMONT, Calif., June 25 /Xinhua-PRNewswire-Fi...on (OTC Bulletin Board: KWBT),announced that on Ju...Co.,Ltd. (Kiwa Shandong) received approval documen...epublic of China, ratifying Kiwa Shandong to,whole...ng chemical,fertilizers, complex fertilizers and c...
...KET, N.Y., June 25 Lixte,Biotechnology Holdings (...,National Institute of Neurological Disorders and ...) and Lixte Biotechnology Holdings, Inc. extended,...nt (CRADA) to develop,drugs for the treatment of b...as extended through September 2009., Dr. John S. ...
... Mich., June 25 MichBio announced that,Johnson & ...he keynote,speaker for its statewide Expo and Conf... the association for Michigan,s life science indus...e science event attracting,more than 450 attendees...of the most respected professionals in the industr...
Other Biology Technology:Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the People's Republic of China to Wholesale Other Fertilizer Manufacturers Products 2Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the People's Republic of China to Wholesale Other Fertilizer Manufacturers Products 3Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 2Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 3Christine Poon Will Keynote MichBio Expo 2Christine Poon Will Keynote MichBio Expo 3
(Date:11/25/2009)... Death Research Laboratory in the University of Ha...prestigious Johnson & Johnson Focused Funding gran...ll damage in Parkinson,s disease. The award, which...innovation and excellence in science, was announce...onth at an event at the Hyatt Regency Hotel in New...
(Date:11/25/2009)...rofessors recently received funding from the Natio...beneficial to understanding the environment. The t...ood, assistant professor in the Department of Biol... separate research projects. , His first project... and Functions from the Leaf to the Landscape," wi...
(Date:11/24/2009)...day named 12 new grant recipients for 2009. The aw...work across a broad spectrum of lupus research. Al... potential to drive scientific discovery to ultima...of systemic lupus. , The 2009 grants go to both ...ation and include interdisciplinary and highly pro...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Advocate Christ Medical Center Redesignated A 26apos 3BMagnet 26apos 3B Hospital the Highest Nursing Honor 57449 1Advocate Christ Medical Center Redesignated A 26apos 3BMagnet 26apos 3B Hospital the Highest Nursing Honor 57449 2Advocate Christ Medical Center Redesignated A 26apos 3BMagnet 26apos 3B Hospital the Highest Nursing Honor 57449 3Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 1Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 2InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture 57446 1InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture 57446 2
...ct. 25, 2007 -- The genes that make a fruit fly,s ...iconius butterfly found in South and Central Ameri... , Bob Reed, assistant professor of ecology and e...d in making insect eye pigments evolved over time ...nding sheds light on the genetic causes of wing pa...
...ah biologists genetically manipulated nematode wor...ame sex part of a study that shows sexual orienta...ok like girls, but act and think like boys, says J...thor of the new study. The [same-sex attraction] b...dy was published online Thursday, Oct. 25 in Curre...
...ale School of Medicine researchers have received $...wn chromosomes and DNA after damage caused by radi...e National Institutes of Health (NIH) is the next ... the lead researcher, Peter Glazer, M.D., chair of...ogy research program at Yale Cancer Center. , W...
Other Biology News:Scientists alter sexual orientation in worms 2Scientists alter sexual orientation in worms 3Scientists alter sexual orientation in worms 4Yale receives $8.4 million to study DNA repair in cancer cells 2
... Alkaline Phosphatase Conjugation Horseradish P...cein Isothiocyanate Conjugation R. Phycoerythrin ...n Conjugation Alexa Fluor 488 Conjugation Alexa ... Rpe-Alexa Fluor 750 Conjugation Apc-Alexa Fluor...
...de Synthesis , 20 Amino Acid length max , MS-sp... customer for future usage conjugation of peptide ...2 days/each , Pre-immune bleed x1 /each , Im...leed (app. 5 ml) x1 /each , Production bleed (...
Rat TIMP-1 ELISA development Kit, DuoSet from R&D Systems
...ted Capture Antibody: 12 x 8-well strips, 3 plasti... 2X concentrate , Beta Amyloid 1-40 Standard: 1...d Standard Diluent: 3 mL , Primary Antibody: 150...HRP: 30 microL of concentrate , OPD Substrate: 2...
Biology Products: